data_2m0x_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m0x _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.475 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.86 0.362 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 23' ' ' ILE . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 32.7 m170 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.435 ' CG2' ' HZ2' ' A' ' 33' ' ' LYS . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HZ2' ' CG2' ' A' ' 13' ' ' THR . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.545 ' H ' ' HZ2' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.45 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.45 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 47.5 t30 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.501 ' N ' HE22 ' A' ' 41' ' ' GLN . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.501 HE22 ' N ' ' A' ' 31' ' ' GLN . 86.3 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 55' ' ' THR . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HZ2' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 34.5 m170 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 32' ' ' ASP . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 30' ' ' ILE . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.714 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 m120 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.511 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 1' ' ' MET . 5.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.595 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.524 -0.037 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' C ' ' OD1' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.486 ' HE ' HE21 ' A' ' 49' ' ' GLN . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.486 HE21 ' HE ' ' A' ' 42' ' ' ARG . 47.3 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 31.1 m170 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.775 0.322 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.687 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.569 ' HG1' ' HG ' ' A' ' 57' ' ' SER . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.569 ' HG ' ' HG1' ' A' ' 55' ' ' THR . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 33.2 m170 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.681 0.277 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . 0.508 ' CG ' HD21 ' A' ' 25' ' ' ASN . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 23' ' ' ILE . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.508 HD21 ' CG ' ' A' ' 21' ' ' ASP . 53.1 t30 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.502 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.567 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' A' ' 55' ' ' THR . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 61' ' ' ILE . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . 0.62 ' HG1' ' H ' ' A' ' 36' ' ' LEU . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.62 ' H ' ' HG1' ' A' ' 34' ' ' THR . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.533 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.533 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -73.02 116.01 13.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.04 168.59 37.41 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.1 mt -66.1 -33.45 75.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.414 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -75.72 -11.95 60.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.742 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -15.28 62.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -78.25 132.74 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p -84.9 146.55 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.475 ' CG ' ' HZ3' ' A' ' 29' ' ' LYS . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.475 ' HZ3' ' CG ' ' A' ' 25' ' ' ASN . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.67 110.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -96.87 116.36 29.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.401 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -155.4 135.8 13.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.94 130.87 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.666 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -70.31 0.63 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.444 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.81 171.08 33.58 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.731 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.758 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -80.6 129.24 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.11 -179.42 30.17 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 mt -63.0 -42.11 99.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.0 7.09 29.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.87 26.42 62.55 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -86.8 116.24 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 110.359 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p -82.64 132.69 35.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.423 HG21 HD13 ' A' ' 23' ' ' ILE . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.497 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 32.7 m170 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.63 120.56 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -146.76 113.43 6.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.613 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -154.32 125.13 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.996 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.14 143.27 41.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -66.54 -37.37 84.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.02 173.84 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.74 0 CA-C-O 117.902 -1.499 . . . . 0.0 110.908 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 105.26 4.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.69 44.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.58 -38.02 88.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -58.99 -53.42 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -43.07 0.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.67 136.24 37.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p -74.02 165.36 25.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.435 ' CG2' ' HZ2' ' A' ' 33' ' ' LYS . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.435 ' HZ2' ' CG2' ' A' ' 13' ' ' THR . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.46 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.45 140.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -128.09 132.54 49.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -61.34 -48.31 81.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.38 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.12 137.97 49.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.515 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.85 145.11 25.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.675 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.47 -3.86 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.064 -1.409 . . . . 0.0 111.033 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.545 ' H ' ' HZ2' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -91.45 105.85 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.46 170.04 46.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 99.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.422 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.3 p -150.16 -9.46 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.26 177.29 53.7 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.92 167.06 21.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 110.522 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -79.58 165.61 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.644 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.45 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.45 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 47.5 t30 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.556 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.501 ' N ' HE22 ' A' ' 41' ' ' GLN . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.556 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.501 HE22 ' N ' ' A' ' 31' ' ' GLN . 86.3 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 55' ' ' THR . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . 0.545 ' HZ2' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.562 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 34.5 m170 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.86 130.73 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -153.8 118.84 5.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.72 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -158.81 128.53 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.51 148.7 31.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.619 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -81.64 146.81 29.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.22 -89.9 0.08 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.932 -1.482 . . . . 0.0 111.017 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -84.78 96.8 9.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.01 163.47 54.95 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.6 -42.39 95.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.7 m -60.65 -50.02 75.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.635 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 -24.85 2.65 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -74.36 121.2 21.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.0 110.203 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -83.95 168.92 15.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.67 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.43 ' C ' ' H ' ' A' ' 32' ' ' ASP . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.43 ' H ' ' C ' ' A' ' 30' ' ' ILE . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.714 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.714 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 m120 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -103.51 132.57 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -137.82 122.43 18.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.575 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -172.49 121.45 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.423 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 9.3 mp -83.13 114.0 21.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.506 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -88.97 138.33 31.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.271 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 163.57 17.64 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.049 -1.417 . . . . 0.0 110.984 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.511 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 1' ' ' MET . 5.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -88.69 107.12 18.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.06 -174.14 50.16 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.73 -41.56 99.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -66.75 -22.12 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 1.44 62.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -81.61 138.74 35.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p -88.35 129.2 35.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.47 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.595 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.595 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.54 139.98 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.86 116.24 9.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.712 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -157.65 116.94 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.0 mt -76.01 114.26 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -92.02 147.69 22.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.549 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.65 -151.69 29.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.771 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.987 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -126.44 93.56 3.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.55 30.87 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 mt -45.27 -67.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -138.76 4.96 2.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.802 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.24 156.72 47.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -66.52 143.79 56.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -63.83 138.86 58.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.277 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' C ' ' OD1' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.534 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.534 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.435 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.486 ' HE ' HE21 ' A' ' 49' ' ' GLN . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.486 HE21 ' HE ' ' A' ' 42' ' ' ARG . 47.3 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.575 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 31.1 m170 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t -90.27 98.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -98.62 116.71 31.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -160.83 108.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.621 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.0 mt -78.24 143.65 36.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.111 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -70.98 148.74 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.8 -33.37 82.74 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.784 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.923 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -86.2 136.85 33.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 -175.48 23.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.2 mp -81.28 -10.19 59.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.973 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -59.76 -13.84 11.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 -0.53 89.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.93 155.71 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p -82.7 162.18 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.786 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.687 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.569 ' HG1' ' HG ' ' A' ' 57' ' ' SER . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.569 ' HG ' ' HG1' ' A' ' 55' ' ' THR . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.687 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 33.2 m170 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -105.49 131.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.4 t90 -108.88 109.9 21.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.264 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -156.26 131.16 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.585 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.01 161.34 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.04 158.64 32.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.313 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.16 -85.15 0.1 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.754 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -84.2 115.0 22.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.64 178.16 40.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -64.3 -41.93 96.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -77.57 -7.07 55.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.595 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.39 -6.36 82.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.32 126.62 29.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p -85.71 135.5 33.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.668 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . 0.508 ' CG ' HD21 ' A' ' 25' ' ' ASN . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.419 HD11 HG23 ' A' ' 23' ' ' ILE . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.508 HD21 ' CG ' ' A' ' 21' ' ' ASP . 53.1 t30 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.502 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.567 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . 0.438 ' H ' ' HG1' ' A' ' 55' ' ' THR . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.502 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 61' ' ' ILE . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t -105.75 124.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -146.51 110.57 5.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.958 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -153.3 150.01 28.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 73' ' ' LEU . 3.2 mm? -80.19 136.33 36.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -76.19 134.88 39.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.406 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.88 -143.56 39.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.88 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -97.1 115.28 27.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.71 174.48 46.37 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.94 -44.31 96.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.389 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -148.87 -21.73 0.31 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.07 -172.8 0.14 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -90.61 146.16 24.28 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 31.9 m -63.53 164.31 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.465 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.465 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . 0.62 ' HG1' ' H ' ' A' ' 36' ' ' LEU . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.91 HD21 ' NE1' ' A' ' 71' ' ' TRP . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.533 ' H ' ' HH ' ' A' ' 59' ' ' TYR . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.533 ' HH ' ' H ' ' A' ' 51' ' ' GLU . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.21 111.19 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.91 ' NE1' HD21 ' A' ' 36' ' ' LEU . 47.5 t90 -117.6 111.67 19.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -171.61 114.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.285 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.413 ' N ' ' CD1' ' A' ' 73' ' ' LEU . 10.4 mp -79.64 142.8 35.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.418 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.3 -45.81 91.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.298 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.72 -141.59 47.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.746 0 CA-C-O 117.975 -1.458 . . . . 0.0 111.111 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.722 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 5' ' ' VAL . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.86 0.362 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 57.5 t-20 -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HG23 ' A' ' 69' ' ' ILE . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HE ' HD11 ' A' ' 44' ' ' ILE . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 ' HE ' ' A' ' 42' ' ' ARG . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.433 HG23 HE22 ' A' ' 41' ' ' GLN . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' H ' ' HE3' ' A' ' 63' ' ' LYS . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 2' ' ' GLN . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' HD22 ' A' ' 67' ' ' LEU . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HZ2' HD12 ' A' ' 43' ' ' LEU . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' GLN . 32.2 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD22 ' A' ' 67' ' ' LEU . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 67' ' ' LEU . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 5' ' ' VAL . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 ' NE2' ' A' ' 41' ' ' GLN . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 30' ' ' ILE . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 8.5 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.524 -0.037 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' C ' ' OD1' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 58' ' ' ASP . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' C ' HD22 ' A' ' 67' ' ' LEU . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 5' ' ' VAL . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.775 0.322 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 36' ' ' LEU . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' HD22 ' A' ' 67' ' ' LEU . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.681 0.277 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.587 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 13' ' ' THR . 31.9 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.447 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 5' ' ' VAL . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -73.02 116.01 13.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.04 168.59 37.41 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.1 mt -66.1 -33.45 75.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.414 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -75.72 -11.95 60.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.742 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -15.28 62.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -78.25 132.74 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p -84.9 146.55 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' O ' ' OD1' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.722 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.67 110.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -96.87 116.36 29.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.401 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -155.4 135.8 13.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.94 130.87 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.666 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -70.31 0.63 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.444 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.81 171.08 33.58 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.731 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.758 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 5' ' ' VAL . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -80.6 129.24 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.11 -179.42 30.17 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 mt -63.0 -42.11 99.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.0 7.09 29.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.87 26.42 62.55 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -86.8 116.24 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 110.359 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p -82.64 132.69 35.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.523 ' OD1' ' ND2' ' A' ' 25' ' ' ASN . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.523 ' ND2' ' OD1' ' A' ' 21' ' ' ASP . 57.5 t-20 -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HG23 ' A' ' 69' ' ' ILE . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HE ' HD11 ' A' ' 44' ' ' ILE . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 ' HE ' ' A' ' 42' ' ' ARG . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 48.9 m-70 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.433 HG23 HE22 ' A' ' 41' ' ' GLN . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.63 120.56 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -146.76 113.43 6.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.613 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -154.32 125.13 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.996 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.14 143.27 41.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -66.54 -37.37 84.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.02 173.84 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.74 0 CA-C-O 117.902 -1.499 . . . . 0.0 110.908 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' H ' ' HE3' ' A' ' 63' ' ' LYS . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 105.26 4.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.69 44.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.58 -38.02 88.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -58.99 -53.42 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -43.07 0.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.67 136.24 37.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p -74.02 165.36 25.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' CD1' ' N ' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.565 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 2' ' ' GLN . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' HD22 ' A' ' 67' ' ' LEU . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.45 140.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -128.09 132.54 49.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -61.34 -48.31 81.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.38 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.12 137.97 49.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.515 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.85 145.11 25.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.675 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.47 -3.86 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.064 -1.409 . . . . 0.0 111.033 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -91.45 105.85 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.46 170.04 46.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 99.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.422 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.3 p -150.16 -9.46 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.26 177.29 53.7 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.92 167.06 21.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 110.522 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -79.58 165.61 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.644 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HZ2' HD12 ' A' ' 43' ' ' LEU . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.416 ' C ' ' O ' ' A' ' 40' ' ' GLN . 32.2 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD22 ' A' ' 67' ' ' LEU . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 56.1 m-70 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.86 130.73 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -153.8 118.84 5.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.72 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -158.81 128.53 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.51 148.7 31.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.619 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -81.64 146.81 29.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.22 -89.9 0.08 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.932 -1.482 . . . . 0.0 111.017 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -84.78 96.8 9.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.01 163.47 54.95 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.6 -42.39 95.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.7 m -60.65 -50.02 75.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.635 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 -24.85 2.65 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -74.36 121.2 21.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.0 110.203 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -83.95 168.92 15.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.67 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 24.8 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 13.3 m-20 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 67' ' ' LEU . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -103.51 132.57 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -137.82 122.43 18.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.575 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -172.49 121.45 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.423 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.3 mp -83.13 114.0 21.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.506 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -88.97 138.33 31.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.271 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 163.57 17.64 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.049 -1.417 . . . . 0.0 110.984 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.478 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 5' ' ' VAL . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -88.69 107.12 18.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.06 -174.14 50.16 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.73 -41.56 99.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -66.75 -22.12 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 1.44 62.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -81.61 138.74 35.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p -88.35 129.2 35.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.47 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 ' NE2' ' A' ' 41' ' ' GLN . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.3 mm-40 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 30' ' ' ILE . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.54 139.98 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.86 116.24 9.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.712 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -157.65 116.94 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.0 mt -76.01 114.26 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -92.02 147.69 22.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.549 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.65 -151.69 29.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.771 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.987 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 8.5 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -126.44 93.56 3.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.55 30.87 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 mt -45.27 -67.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -138.76 4.96 2.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.802 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.24 156.72 47.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -66.52 143.79 56.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -63.83 138.86 58.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.277 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' C ' ' OD1' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 58' ' ' ASP . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' C ' HD22 ' A' ' 67' ' ' LEU . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t -90.27 98.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -98.62 116.71 31.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -160.83 108.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.621 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.0 mt -78.24 143.65 36.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.111 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -70.98 148.74 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.8 -33.37 82.74 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.784 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.923 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 5' ' ' VAL . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -86.2 136.85 33.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 -175.48 23.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' H ' HD12 ' A' ' 8' ' ' LEU . 5.2 mp -81.28 -10.19 59.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.973 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -59.76 -13.84 11.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 -0.53 89.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.93 155.71 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p -82.7 162.18 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.786 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 36' ' ' LEU . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' HD22 ' A' ' 67' ' ' LEU . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.0 m-70 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -105.49 131.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.4 t90 -108.88 109.9 21.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.264 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -156.26 131.16 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.585 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.01 161.34 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.04 158.64 32.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.313 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.16 -85.15 0.1 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.754 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -84.2 115.0 22.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.64 178.16 40.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -64.3 -41.93 96.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -77.57 -7.07 55.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.595 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.39 -6.36 82.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.32 126.62 29.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p -85.71 135.5 33.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.668 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.3 t-20 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.554 ' O ' HD12 ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.587 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t -105.75 124.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -146.51 110.57 5.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.958 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -153.3 150.01 28.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.2 mm? -80.19 136.33 36.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -76.19 134.88 39.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.406 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.88 -143.56 39.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.88 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -97.1 115.28 27.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.71 174.48 46.37 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.94 -44.31 96.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.389 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -148.87 -21.73 0.31 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.07 -172.8 0.14 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -90.61 146.16 24.28 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 13' ' ' THR . 31.9 m -63.53 164.31 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.828 HD21 ' NE1' ' A' ' 71' ' ' TRP . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.516 ' OE1' HD11 ' A' ' 73' ' ' LEU . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.447 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.21 111.19 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.828 ' NE1' HD21 ' A' ' 36' ' ' LEU . 47.5 t90 -117.6 111.67 19.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -171.61 114.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.285 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.4 mp -79.64 142.8 35.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.418 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.3 -45.81 91.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.298 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.72 -141.59 47.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.746 0 CA-C-O 117.975 -1.458 . . . . 0.0 111.111 179.79 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p . . . . . 0 N--CA 1.461 0.115 0 CA-C-O 120.766 0.317 . . . . 0.0 111.01 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.722 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp . . . . . 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.86 0.362 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HG23 ' A' ' 69' ' ' ILE . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HE ' HD11 ' A' ' 44' ' ' ILE . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 ' HE ' ' A' ' 42' ' ' ARG . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 32.7 m170 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.433 HG23 HE22 ' A' ' 41' ' ' GLN . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.407 ' H ' ' HE3' ' A' ' 63' ' ' LYS . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p . . . . . 0 CA--C 1.52 -0.18 0 CA-C-O 120.829 0.347 . . . . 0.0 110.677 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 2' ' ' GLN . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' HD22 ' A' ' 67' ' ' LEU . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.476 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.824 0.345 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.454 ' CG ' HD22 ' A' ' 25' ' ' ASN . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.454 HD22 ' CG ' ' A' ' 21' ' ' ASP . 47.5 t30 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HZ2' HD12 ' A' ' 43' ' ' LEU . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.517 ' N ' HE22 ' A' ' 41' ' ' GLN . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.517 HE22 ' N ' ' A' ' 31' ' ' GLN . 86.3 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD22 ' A' ' 67' ' ' LEU . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 34.5 m170 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt . . . . . 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.784 0.326 . . . . 0.0 110.67 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.429 ' CA ' HE22 ' A' ' 41' ' ' GLN . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.429 HE22 ' CA ' ' A' ' 31' ' ' GLN . 96.7 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 m120 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 67' ' ' LEU . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t . . . . . 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.511 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 1' ' ' MET . 5.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt . . . . . 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.779 0.323 . . . . 0.0 110.47 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 ' NE2' ' A' ' 41' ' ' GLN . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 30' ' ' ILE . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m . . . . . 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 3.2 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp . . . . . 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m . . . . . 0 CA--C 1.524 -0.037 0 CA-C-O 120.864 0.364 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.414 ' OD1' ' C ' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.534 ' HE ' HE21 ' A' ' 49' ' ' GLN . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.534 HE21 ' HE ' ' A' ' 42' ' ' ARG . 47.3 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 58' ' ' ASP . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' C ' HD22 ' A' ' 67' ' ' LEU . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 31.1 m170 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t . . . . . 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 5' ' ' VAL . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.775 0.322 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 36' ' ' LEU . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.504 HE21 HD11 ' A' ' 36' ' ' LEU . 91.7 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' HD22 ' A' ' 67' ' ' LEU . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 33.2 m170 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m . . . . . 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p . . . . . 0 N--CA 1.461 0.106 0 CA-C-O 120.681 0.277 . . . . 0.0 110.668 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.546 ' CG ' HD22 ' A' ' 25' ' ' ASN . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.546 HD22 ' CG ' ' A' ' 21' ' ' ASP . 53.1 t30 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.587 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp . . . . . 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 13' ' ' THR . 31.9 m . . . . . 0 C--O 1.231 0.123 0 N-CA-C 110.278 -0.267 . . . . 0.0 110.278 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.447 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 46.3 ttp . . . . . 0 N--CA 1.489 1.521 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -92.6 174.13 7.43 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.639 -179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.9 pt -146.92 150.42 14.84 Favored 'Isoleucine or valine' 0 C--O 1.232 0.181 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.319 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 4' ' ' PHE . 2.1 m-85 -107.14 127.37 53.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.0 179.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.522 ' O ' HG23 ' A' ' 5' ' ' VAL . 18.0 m -108.08 128.27 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.568 -179.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -73.02 116.01 13.03 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.447 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -88.04 168.59 37.41 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.94 -0.864 . . . . 0.0 110.94 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.1 mt -66.1 -33.45 75.82 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.936 0.398 . . . . 0.0 110.414 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.3 p -75.72 -11.95 60.1 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.742 -179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 97.73 -15.28 62.09 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 110.126 -1.19 . . . . 0.0 110.126 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -78.25 132.74 37.65 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 40.3 p -84.9 146.55 27.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.01 -179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.486 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -122.04 111.27 16.82 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.053 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.508 ' O ' ' NZ ' ' A' ' 33' ' ' LYS . 19.0 p -67.98 136.78 54.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.717 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.9 mt -130.54 142.37 50.47 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.209 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -89.95 120.41 31.15 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.311 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.4 m -143.53 166.84 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.262 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.534 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.456 ' O ' ' N ' ' A' ' 21' ' ' ASP . 74.7 mt-10 -143.89 148.84 43.98 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.826 179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_exo -39.28 -38.18 1.28 Allowed 'Trans proline' 0 N--CA 1.49 1.265 0 C-N-CA 121.833 1.689 . . . . 0.0 111.746 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 77.4 p -74.35 -37.2 63.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.658 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 18' ' ' GLU . 30.5 t70 -52.29 118.23 3.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.072 0.463 . . . . 0.0 110.707 -179.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 70.2 p -81.13 163.17 23.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.662 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -61.44 -42.98 95.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.495 -179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.7 tt0 -46.52 -43.15 16.67 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.838 -0.43 . . . . 0.0 109.838 179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t-20 -66.52 -43.93 83.88 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.047 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.27 -48.36 79.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.714 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -58.97 -33.46 70.7 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -67.07 -42.64 84.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.22 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 53.1 mttp -60.0 -42.41 94.22 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.1 mt -63.25 -44.28 99.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.537 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 49.5 tt0 -52.56 -13.86 0.43 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.872 -179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 41.2 m-20 -97.34 -41.57 8.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.521 -0.309 . . . . 0.0 111.35 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' NZ ' ' O ' ' A' ' 14' ' ' THR . 96.0 mttt -78.09 -33.02 50.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.542 -0.299 . . . . 0.0 111.254 -179.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.1 p -97.26 -23.23 16.25 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.854 0.359 . . . . 0.0 110.375 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 67.63 2.6 22.73 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.024 -0.83 . . . . 0.0 111.024 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 80.3 mt -80.06 147.8 66.36 Favored Pre-proline 0 CA--C 1.532 0.261 0 C-N-CA 120.997 -0.281 . . . . 0.0 110.627 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.1 161.92 42.29 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.209 1.939 . . . . 0.0 111.043 178.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -62.51 -29.82 79.06 Favored 'Trans proline' 0 N--CA 1.498 1.78 0 C-N-CA 122.634 2.223 . . . . 0.0 112.695 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 40.6 p30 -74.66 -7.25 52.66 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.72 -0.392 . . . . 0.0 110.879 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 70.5 mt-30 -112.71 14.75 20.03 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.484 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -117.88 144.17 45.66 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.976 0.417 . . . . 0.0 110.891 -179.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 45.0 ttp180 -152.57 126.41 8.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.624 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 63.0 mt -111.0 126.64 55.0 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.48 -179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 70.4 mt -135.99 128.41 45.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.146 178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -120.69 129.24 53.59 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.83 0.348 . . . . 0.0 110.663 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.47 24.03 4.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.726 179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.67 80.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 60.0 mttp -99.32 132.76 44.42 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.743 0.306 . . . . 0.0 110.23 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -84.59 130.82 34.68 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.912 0.387 . . . . 0.0 111.091 -179.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.0 mt -87.44 158.72 18.91 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.98 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 90.7 mt-10 -143.39 155.08 44.32 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.287 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 53' ' ' GLY . 20.5 t0 -64.2 155.42 31.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.785 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 52' ' ' ASP . . . 89.44 -18.91 43.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.965 -0.854 . . . . 0.0 110.965 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.9 mpt_? -95.77 164.05 12.91 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.943 0.401 . . . . 0.0 110.109 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.8 p -125.17 176.65 6.58 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.058 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 57.5 mt -65.36 -37.7 87.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.037 0.446 . . . . 0.0 110.264 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.7 p -61.65 -22.22 65.09 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.722 179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -81.65 -43.32 18.73 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.906 0.384 . . . . 0.0 110.452 179.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.1 m-85 -83.48 3.27 32.9 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.365 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' OD1' ' O ' ' A' ' 60' ' ' ASN . 57.1 t-20 58.55 25.21 12.84 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.483 -179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 50.3 mt -71.05 123.14 24.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.178 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 83.1 mt-30 -101.24 -162.32 0.93 Allowed 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.666 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.5 tttt -77.4 156.1 31.41 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.54 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 15.8 mt-10 55.09 24.56 6.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.796 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.455 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -66.2 127.69 33.16 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.157 179.899 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 20.3 m -83.68 111.89 19.56 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.994 0.426 . . . . 0.0 111.152 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.722 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -90.04 -162.1 0.85 Allowed 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 89.8 m-70 -155.14 116.83 4.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.003 0.43 . . . . 0.0 110.757 179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 70.9 mt -94.76 110.76 24.35 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.35 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.3 t -104.67 110.3 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.338 179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 24.9 t90 -96.87 116.36 29.04 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.917 0.389 . . . . 0.0 110.401 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.7 ttt180 -155.4 135.8 13.24 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.283 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.5 mt -85.94 130.87 34.42 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.666 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 38.5 ptt180 -70.31 0.63 6.09 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.444 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.81 171.08 33.58 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.731 0 CA-C-O 118.059 -1.412 . . . . 0.0 110.758 179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.1 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 83.5 mt-30 -95.35 169.45 10.06 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.267 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 12.1 pt -143.19 150.45 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-O 121.067 0.461 . . . . 0.0 111.107 -179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.454 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.5 m-85 -103.73 126.98 51.22 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.459 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.49 ' O ' HG23 ' A' ' 5' ' ' VAL . 25.7 m -106.19 127.57 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.938 -179.076 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -80.6 129.24 34.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.673 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -100.11 -179.42 30.17 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 39.7 mt -63.0 -42.11 99.76 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.751 0.31 . . . . 0.0 110.563 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 11.3 p -87.0 7.09 29.11 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.256 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 76.87 26.42 62.55 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 111.292 -0.723 . . . . 0.0 111.292 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.4 tttm -86.8 116.24 24.75 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.831 0.348 . . . . 0.0 110.359 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 20.6 p -82.64 132.69 35.18 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.022 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -125.77 114.17 18.26 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.88 179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 17.9 p -68.55 126.65 30.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.492 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -124.3 136.78 54.37 Favored 'General case' 0 N--CA 1.466 0.365 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.366 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 70.8 tt0 -86.3 121.19 28.52 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.557 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 m -141.5 164.73 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.429 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 85.2 mt-10 -140.96 151.2 61.79 Favored Pre-proline 0 CA--C 1.534 0.35 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.144 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -42.63 -46.29 8.19 Favored 'Trans proline' 0 N--CA 1.491 1.358 0 C-N-CA 121.764 1.643 . . . . 0.0 111.778 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.6 m -67.86 -34.67 77.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.719 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -55.53 119.74 6.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.488 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -82.75 160.63 22.27 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.36 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.7 mm -58.21 -40.66 78.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.665 -179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 76.9 tt0 -47.6 -45.37 27.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.139 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.441 ' O ' ' HB3' ' A' ' 28' ' ' ALA . 0.6 OUTLIER -63.4 -47.58 81.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.243 179.83 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.5 t -53.31 -46.75 57.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.476 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -60.32 -33.57 72.58 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . 0.441 ' HB3' ' O ' ' A' ' 25' ' ' ASN . . . -66.19 -41.87 89.65 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.007 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -62.67 -42.82 99.83 Favored 'General case' 0 C--N 1.331 -0.198 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 179.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.453 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.4 mt -62.97 -43.67 99.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.346 179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.3 tt0 -50.29 -10.62 0.06 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.866 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.453 ' H ' ' C ' ' A' ' 30' ' ' ILE . 54.4 m-20 -99.93 -37.4 9.04 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.956 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -82.88 -32.79 27.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.515 -179.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.1 p -98.15 -25.75 14.8 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.681 0.277 . . . . 0.0 111.036 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 77.03 -10.9 17.49 Favored Glycine 0 CA--C 1.527 0.811 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 28.5 mt -72.95 147.69 88.74 Favored Pre-proline 0 C--N 1.329 -0.291 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -77.77 161.95 30.11 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 121.97 1.78 . . . . 0.0 112.075 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -52.47 -33.11 55.82 Favored 'Trans proline' 0 N--CA 1.5 1.862 0 C-N-CA 122.314 2.009 . . . . 0.0 113.41 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -66.45 -16.54 64.19 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.898 -0.321 . . . . 0.0 111.824 -178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -99.52 -59.92 1.63 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.796 0.332 . . . . 0.0 110.572 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.433 HE22 HG23 ' A' ' 69' ' ' ILE . 10.0 mm100 -38.98 148.46 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.39 0.614 . . . . 0.0 111.802 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.419 ' HE ' HD11 ' A' ' 44' ' ' ILE . 59.0 ttt85 -153.17 135.23 14.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.628 179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 51.7 mt -125.4 133.54 52.47 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 121.138 0.494 . . . . 0.0 111.49 -179.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.419 HD11 ' HE ' ' A' ' 42' ' ' ARG . 67.0 mt -140.66 121.21 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 115.712 -0.677 . . . . 0.0 109.44 178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.422 ' O ' ' N ' ' A' ' 48' ' ' LYS . 60.7 t80 -112.81 134.61 54.24 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.067 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 47.65 26.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.5 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 90.66 -22.13 29.4 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 111.394 -0.683 . . . . 0.0 111.394 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.422 ' N ' ' O ' ' A' ' 45' ' ' PHE . 95.9 mttt -72.08 131.82 43.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.905 0.383 . . . . 0.0 111.114 -179.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -82.15 131.25 35.24 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.507 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -89.39 140.68 29.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.505 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -138.03 146.85 43.53 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.244 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -62.84 106.76 0.86 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.614 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 147.59 -3.78 0.87 Allowed Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 93.6 mtt180 -129.32 137.72 51.17 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 120.8 0.333 . . . . 0.0 110.456 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.4 p -87.03 -177.48 6.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.553 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 61.1 mt -69.37 -35.49 75.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.51 179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.9 t -62.43 -18.42 61.64 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.622 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -84.95 -44.66 12.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.209 179.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.7 m-85 -81.07 5.47 16.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.282 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 56.12 25.72 9.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.345 -179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.9 mt -74.53 127.1 36.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.503 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 15.5 mt-30 -112.59 -151.85 0.49 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.281 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.7 tttt -83.72 154.66 23.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.682 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 55.99 21.59 5.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.604 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.448 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.29 124.53 22.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.18 -0.464 . . . . 0.0 109.868 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 8.0 m -82.64 112.68 19.74 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.912 0.387 . . . . 0.0 111.583 -178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -90.36 -166.54 1.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.529 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 32.7 m170 -147.77 113.35 5.67 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 120.754 0.311 . . . . 0.0 111.193 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.433 HG23 HE22 ' A' ' 41' ' ' GLN . 57.0 mt -95.7 103.71 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.073 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.63 120.56 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.257 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.575 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -146.76 113.43 6.03 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.613 -179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.8 ttm-85 -154.32 125.13 7.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.996 179.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 39.1 mt -76.14 143.27 41.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.774 -179.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 75.1 mtp85 -66.54 -37.37 84.85 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.457 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 174.02 173.84 40.43 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 111.045 -0.822 . . . . 0.0 111.045 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.74 0 CA-C-O 117.902 -1.499 . . . . 0.0 110.908 179.954 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.3 ttp . . . . . 0 N--CA 1.491 1.614 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.407 ' H ' ' HE3' ' A' ' 63' ' ' LYS . 81.0 mt-30 -88.25 175.95 7.45 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.305 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -150.07 145.98 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.606 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.423 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.1 m-85 -103.38 113.23 26.55 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.027 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 26.5 m -90.77 137.24 22.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.665 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -73.3 105.26 4.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.439 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.69 153.69 44.42 Favored Glycine 0 CA--C 1.523 0.542 0 N-CA-C 110.88 -0.888 . . . . 0.0 110.88 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 80.7 mt -62.58 -38.02 88.49 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 0.0 110.306 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.2 m -58.99 -53.42 58.63 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.147 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.66 -43.07 0.59 Allowed Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.949 -0.86 . . . . 0.0 110.949 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.67 136.24 37.4 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.775 0.321 . . . . 0.0 110.436 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.3 p -74.02 165.36 25.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.677 -179.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -127.08 128.83 46.87 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.169 0.509 . . . . 0.0 110.285 -179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 44.2 p -80.06 131.75 35.83 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.036 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.6 mt -129.32 146.12 51.26 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 121.072 0.463 . . . . 0.0 110.203 -179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -90.38 120.84 31.83 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.305 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.4 m -144.79 164.95 12.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.385 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.522 ' N ' ' OE1' ' A' ' 18' ' ' GLU . 56.7 mp0 -142.76 147.92 44.04 Favored Pre-proline 0 CA--C 1.535 0.383 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.159 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -42.28 -47.24 7.24 Favored 'Trans proline' 0 N--CA 1.492 1.395 0 C-N-CA 121.894 1.729 . . . . 0.0 112.137 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 90.2 p -64.99 -32.75 74.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.732 -179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -59.05 126.24 26.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.452 -179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.8 p -83.39 155.69 23.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.476 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.425 ' N ' ' CD1' ' A' ' 23' ' ' ILE . 1.2 mp -58.55 -24.64 25.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 90.0 mt-10 -60.12 -43.26 95.79 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 179.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.7 t30 -68.21 -43.45 78.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.943 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 16.9 t -55.32 -46.85 78.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.144 0 CA-C-N 116.189 -0.459 . . . . 0.0 109.848 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -61.32 -37.24 82.54 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.82 -43.47 88.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.2 mmtt -62.44 -43.46 98.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.659 179.197 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.484 ' C ' ' H ' ' A' ' 32' ' ' ASP . 77.9 mt -62.68 -43.43 98.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.473 179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -49.84 -10.81 0.05 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.011 0.434 . . . . 0.0 110.511 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.484 ' H ' ' C ' ' A' ' 30' ' ' ILE . 56.1 t0 -86.76 -36.42 18.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.589 179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -92.09 -11.31 36.12 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.447 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 64.0 p -113.19 -37.5 4.72 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.866 0.365 . . . . 0.0 110.495 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 58.55 73.62 0.44 Allowed Glycine 0 CA--C 1.526 0.76 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.5 154.26 29.15 Favored Pre-proline 0 CA--C 1.534 0.349 0 N-CA-C 110.097 -0.335 . . . . 0.0 110.097 179.498 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -58.6 162.76 11.99 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 C-N-CA 122.237 1.958 . . . . 0.0 111.451 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -66.45 -24.49 49.42 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.542 2.162 . . . . 0.0 112.348 -179.379 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 52.0 p30 -73.26 -1.33 17.43 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.691 -0.404 . . . . 0.0 110.275 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -116.38 7.17 13.81 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.635 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -92.54 119.74 32.31 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.209 179.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 58.5 ttt85 -141.75 122.04 13.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.09 -0.505 . . . . 0.0 109.897 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 78.0 mt -127.47 135.55 50.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.472 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 66.8 mt -138.39 130.16 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.637 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 77.6 t80 -123.31 132.5 54.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.353 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 51.47 19.11 0.76 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.94 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 96.18 -16.5 61.0 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -80.35 132.92 35.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.821 0.343 . . . . 0.0 110.36 179.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 53.6 tt0 -85.07 130.83 34.55 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.015 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.8 mt -85.49 147.29 26.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.684 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -140.78 163.36 33.12 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.408 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 92.8 m-20 -70.44 143.36 51.81 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.563 -179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.13 11.24 57.72 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 79.6 mtt85 -131.89 130.99 42.34 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-O 120.635 0.255 . . . . 0.0 110.463 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.0 p -90.34 176.61 6.66 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.292 179.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 22.9 mt -65.87 -33.06 74.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.265 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 30.5 m -62.59 -18.27 61.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.094 -179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -83.28 -41.53 18.2 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.093 0.473 . . . . 0.0 109.963 179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 80.3 m-85 -82.24 1.34 37.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.542 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 59.3 25.63 14.31 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.448 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 60.1 mt -74.03 129.87 36.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.412 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.4 mt-30 -112.21 -154.03 0.53 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.2 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.407 ' HE3' ' H ' ' A' ' 2' ' ' GLN . 74.0 tttt -83.17 149.17 27.01 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.753 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 61.71 34.56 17.38 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.896 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.419 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.9 OUTLIER -79.91 130.44 35.3 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.35 179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.407 ' C ' HD22 ' A' ' 67' ' ' LEU . 19.8 m -85.01 112.63 20.78 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-O 120.913 0.387 . . . . 0.0 111.39 -179.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.725 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -92.77 -164.91 1.24 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.587 179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.537 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 35.8 m170 -146.56 108.65 4.41 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 120.783 0.325 . . . . 0.0 111.116 179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 96.7 mt -90.97 116.38 32.07 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.172 0 CA-C-O 120.943 0.402 . . . . 0.0 110.034 179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -117.45 140.13 41.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.488 -178.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 1.4 t90 -128.09 132.54 49.0 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 109.19 -0.67 . . . . 0.0 109.19 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -61.34 -48.31 81.89 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.38 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 2.6 pp -71.12 137.97 49.29 Favored 'General case' 0 C--N 1.331 -0.197 0 C-N-CA 120.921 -0.312 . . . . 0.0 110.515 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 12.3 ptm180 -150.85 145.11 25.46 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.675 -179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -86.47 -3.86 83.81 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.221 -0.672 0 CA-C-O 118.064 -1.409 . . . . 0.0 111.033 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 40.4 ttp . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.476 ' H ' ' NZ ' ' A' ' 63' ' ' LYS . 84.6 mt-30 -94.07 174.6 7.07 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.959 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 23.1 pt -149.24 144.14 18.18 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.08 179.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.458 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.0 m-30 -100.89 119.89 39.34 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 121.032 0.444 . . . . 0.0 110.618 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -87.94 124.9 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.235 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.391 179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -91.45 105.85 18.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.543 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -70.46 170.04 46.19 Favored Glycine 0 CA--C 1.524 0.628 0 N-CA-C 110.835 -0.906 . . . . 0.0 110.835 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 62.3 mt -62.41 -41.89 99.02 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.985 -0.286 . . . . 0.0 110.422 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.3 p -150.16 -9.46 0.28 Allowed 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.014 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.26 177.29 53.7 Favored Glycine 0 CA--C 1.525 0.687 0 N-CA-C 111.112 -0.795 . . . . 0.0 111.112 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -72.92 167.06 21.8 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.741 0.305 . . . . 0.0 110.522 179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 70.9 p -79.58 165.61 22.76 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.644 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' HG22 ' A' ' 5' ' ' VAL . 9.4 m -142.82 128.91 19.7 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.28 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 76.8 p -85.82 124.67 32.57 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.547 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.5 mt -112.58 141.08 46.77 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.533 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -85.86 119.45 26.18 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.058 -0.519 . . . . 0.0 109.913 179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 32.3 m -140.72 168.96 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.668 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -148.1 153.79 42.02 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.792 179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_exo -42.5 -45.65 8.12 Favored 'Trans proline' 0 N--CA 1.492 1.412 0 C-N-CA 121.854 1.703 . . . . 0.0 112.238 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 40.8 p -70.94 -32.96 70.0 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.454 ' CG ' HD22 ' A' ' 25' ' ' ASN . 21.2 t70 -53.63 107.65 0.27 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.473 -0.331 . . . . 0.0 110.473 -179.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 29.5 p -70.56 166.33 20.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.499 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.9 mm -61.41 -42.26 93.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.844 -179.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 80.8 tt0 -44.71 -44.45 9.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.816 0.341 . . . . 0.0 110.747 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.454 HD22 ' CG ' ' A' ' 21' ' ' ASP . 47.5 t30 -65.43 -43.32 90.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.622 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 31.0 t -56.89 -49.25 79.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.964 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HZ2' HD12 ' A' ' 43' ' ' LEU . 58.2 mttp -60.76 -35.08 75.49 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.365 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.52 -40.54 95.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.405 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 62.9 mmtt -65.76 -42.65 90.63 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.506 ' C ' ' H ' ' A' ' 32' ' ' ASP . 85.9 mt -61.86 -40.59 87.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.627 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.517 ' N ' HE22 ' A' ' 41' ' ' GLN . 49.2 tt0 -51.87 -6.33 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.84 0.352 . . . . 0.0 110.85 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' H ' ' C ' ' A' ' 30' ' ' ILE . 49.7 m-20 -89.26 -33.87 16.81 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.861 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -100.8 -8.66 22.45 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.703 -179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 18.7 p -115.12 -47.59 2.85 Favored 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.509 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 83.61 -9.28 62.53 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 22.0 mt -64.94 147.41 98.4 Favored Pre-proline 0 CA--C 1.533 0.311 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -74.39 157.29 45.46 Favored 'Trans proline' 0 N--CA 1.495 1.582 0 C-N-CA 122.258 1.972 . . . . 0.0 112.024 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -49.29 -36.98 39.14 Favored 'Trans proline' 0 N--CA 1.498 1.772 0 C-N-CA 122.294 1.996 . . . . 0.0 113.276 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -64.75 -7.65 11.75 Favored 'General case' 0 C--N 1.33 -0.27 0 C-N-CA 121.009 -0.276 . . . . 0.0 111.737 -178.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.416 ' O ' ' C ' ' A' ' 41' ' ' GLN . 57.7 mt-30 -112.47 -63.51 1.42 Allowed 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.517 HE22 ' N ' ' A' ' 31' ' ' GLN . 86.3 mt-30 -31.08 95.68 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.261 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 -104.52 137.34 42.52 Favored 'General case' 0 N--CA 1.468 0.432 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.212 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.425 HD12 ' HZ2' ' A' ' 27' ' ' LYS . 98.2 mt -126.64 135.14 50.81 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-O 121.07 0.462 . . . . 0.0 110.896 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 92.1 mt -138.57 128.38 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.591 179.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.401 ' C ' ' N ' ' A' ' 47' ' ' GLY . 65.7 t80 -122.44 136.99 55.01 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.806 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.0 18.3 0.36 Allowed 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.317 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.401 ' N ' ' C ' ' A' ' 45' ' ' PHE . . . 99.14 -31.94 7.69 Favored Glycine 0 CA--C 1.526 0.758 0 N-CA-C 110.808 -0.917 . . . . 0.0 110.808 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -68.13 139.35 56.16 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.815 0.341 . . . . 0.0 110.624 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -90.23 136.87 32.79 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.3 mt -88.28 147.77 24.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.543 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 64.9 tt0 -146.1 149.17 33.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.423 -179.403 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -53.56 155.09 3.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.728 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 82.39 18.84 65.61 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 67.9 mmt-85 -137.65 144.21 41.76 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-O 120.967 0.413 . . . . 0.0 110.577 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 18.6 p -101.64 169.67 8.68 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.175 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.8 mt -64.27 -35.82 82.09 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.015 0.436 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 56.3 p -61.05 -17.3 51.59 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.716 -0.674 . . . . 0.0 111.302 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 -86.09 -39.6 16.58 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-O 120.857 0.361 . . . . 0.0 110.347 179.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -82.33 -1.74 50.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.595 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.1 m-20 63.34 25.41 14.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.174 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 61.8 mt -75.06 126.18 35.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.299 179.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 66.8 mt-30 -110.35 -155.73 0.57 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.413 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . 0.476 ' NZ ' ' H ' ' A' ' 2' ' ' GLN . 41.5 tttp -79.09 162.22 25.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.1 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 47.59 19.23 0.14 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.762 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.449 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 3.6 m -63.35 124.43 21.24 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.434 ' C ' HD22 ' A' ' 67' ' ' LEU . 1.8 m -82.28 116.12 21.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.071 0.462 . . . . 0.0 111.323 -178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.697 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -93.38 -176.77 4.22 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.117 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.533 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 34.5 m170 -143.76 119.58 10.56 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.808 0.337 . . . . 0.0 110.862 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 66.9 mt -94.74 113.82 30.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.23 179.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.86 130.73 45.06 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.228 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.526 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.0 t90 -153.8 118.84 5.06 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.72 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 70.4 ttp85 -158.81 128.53 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.447 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.51 148.7 31.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.619 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 82.3 mtp180 -81.64 146.81 29.87 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.452 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -173.22 -89.9 0.08 OUTLIER Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.723 0 CA-C-O 117.932 -1.482 . . . . 0.0 111.017 179.972 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.3 ptm . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -90.1 173.93 7.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.604 179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.5 pt -145.24 143.41 22.15 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.168 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.744 179.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.475 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 2.0 m-30 -99.78 113.19 25.52 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.306 0.574 . . . . 0.0 110.992 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.32 129.08 38.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.242 -0.89 . . . . 0.0 109.604 179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -84.78 96.8 9.39 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 109.938 -0.393 . . . . 0.0 109.938 179.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -73.01 163.47 54.95 Favored Glycine 0 CA--C 1.524 0.61 0 N-CA-C 111.12 -0.792 . . . . 0.0 111.12 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 16.9 mt -64.6 -42.39 95.59 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.731 0.301 . . . . 0.0 110.795 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 31.7 m -60.65 -50.02 75.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.635 -179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 140.34 -24.85 2.65 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.335 -1.106 . . . . 0.0 110.335 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 7.8 ttpm? -74.36 121.2 21.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.803 0.335 . . . . 0.0 110.203 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 66.7 p -83.95 168.92 15.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.67 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.3 m -143.31 127.46 17.55 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.15 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 66.9 p -83.23 103.15 12.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.408 -179.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 49.3 mt -88.55 132.78 34.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.852 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 31.9 tp10 -75.25 116.98 16.57 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.2 m -141.17 169.38 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 121.18 0.514 . . . . 0.0 111.225 -179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -149.79 150.44 30.43 Favored Pre-proline 0 CA--C 1.532 0.268 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.432 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_exo -38.74 -47.16 2.69 Favored 'Trans proline' 0 N--CA 1.49 1.267 0 C-N-CA 122.053 1.835 . . . . 0.0 112.27 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 66.6 m -66.52 -35.58 80.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.963 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -49.84 119.28 3.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.874 0.369 . . . . 0.0 110.742 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 68.9 p -80.88 163.82 23.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.34 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 21.8 mm -61.89 -41.52 91.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.437 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 37.5 tp10 -47.36 -44.12 23.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.263 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -65.2 -43.91 90.07 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.345 179.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 48.7 t -55.0 -45.11 76.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.112 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -64.97 -34.15 77.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.005 179.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.55 -41.97 92.4 Favored 'General case' 0 C--N 1.331 -0.228 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -62.02 -40.68 96.51 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 76.9 mt -68.06 -45.38 83.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.527 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.429 ' CA ' HE22 ' A' ' 41' ' ' GLN . 50.9 tt0 -53.55 -10.7 0.28 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.253 -179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 78.7 m-20 -92.9 -36.76 12.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.774 0.321 . . . . 0.0 110.494 179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -89.47 -21.38 23.0 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.65 -179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.2 p -107.68 -34.01 7.12 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.651 0.263 . . . . 0.0 110.773 -179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 74.54 4.94 71.66 Favored Glycine 0 CA--C 1.526 0.769 0 N-CA-C 111.54 -0.624 . . . . 0.0 111.54 179.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 67.8 mt -78.61 148.19 72.74 Favored Pre-proline 0 CA--C 1.534 0.336 0 C-N-CA 120.761 -0.376 . . . . 0.0 110.348 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 71.0 Cg_endo -73.37 161.17 43.27 Favored 'Trans proline' 0 N--CA 1.496 1.636 0 C-N-CA 122.247 1.965 . . . . 0.0 111.731 179.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -64.26 -29.04 63.98 Favored 'Trans proline' 0 N--CA 1.497 1.679 0 C-N-CA 122.572 2.181 . . . . 0.0 112.019 179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -67.38 -10.82 54.89 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.523 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 52.5 mm-40 -107.09 -67.89 0.92 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.632 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.429 HE22 ' CA ' ' A' ' 31' ' ' GLN . 96.7 mt-30 -32.19 146.19 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.02 -179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 57.0 ttm-85 -151.94 127.38 10.0 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.161 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 75.0 mt -113.73 128.71 56.52 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.327 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 95.5 mt -137.38 129.26 41.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.269 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.018 179.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 53.6 t80 -121.01 123.69 43.0 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.07 179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 58.48 9.63 1.13 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.768 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 109.99 -23.91 20.2 Favored Glycine 0 CA--C 1.527 0.832 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -72.77 137.08 45.62 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.866 0.365 . . . . 0.0 110.863 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.1 tt0 -86.33 132.54 33.95 Favored 'General case' 0 N--CA 1.463 0.185 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.534 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 16.1 mt -91.5 136.92 32.77 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.703 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.21 155.86 49.01 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.564 -179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -57.57 158.78 5.6 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.711 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 83.17 7.29 87.09 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 73.7 mmt-85 -128.42 145.94 50.94 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.789 0.328 . . . . 0.0 110.465 -179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.0 p -107.85 167.72 9.78 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 51.6 mt -62.2 -37.89 87.03 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.553 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 16.9 m -59.85 -19.73 52.8 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.685 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 42.9 t0 -83.75 -41.17 17.92 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.668 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -82.74 2.72 32.4 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.511 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' N ' ' ND2' ' A' ' 60' ' ' ASN . 3.4 m120 59.87 25.19 14.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.237 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 63.4 mt -74.57 126.48 35.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.472 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -110.5 -167.22 1.16 Allowed 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.59 -179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 75.3 tttt -70.67 157.2 38.39 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.967 0.413 . . . . 0.0 110.738 -179.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 53.49 22.65 3.02 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.743 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -68.86 127.84 34.54 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.401 ' C ' HD22 ' A' ' 67' ' ' LEU . 8.0 m -83.74 113.46 20.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.106 0.479 . . . . 0.0 111.875 -178.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.715 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.8 mm? -92.64 -163.18 1.01 Allowed 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CG ' ' O ' ' A' ' 67' ' ' LEU . 94.0 m-70 -158.47 123.01 4.15 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.822 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 59.1 mt -102.95 110.31 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.0 179.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.8 t -103.51 132.57 49.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.415 -179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 29.1 t90 -137.82 122.43 18.56 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.575 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 62.2 ttt-85 -172.49 121.45 0.42 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.423 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.559 ' N ' HD12 ' A' ' 73' ' ' LEU . 9.3 mp -83.13 114.0 21.02 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.506 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 60.3 ttt85 -88.97 138.33 31.51 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.271 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.34 163.57 17.64 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.143 -0.783 . . . . 0.0 111.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.798 0 CA-C-O 118.049 -1.417 . . . . 0.0 110.984 179.929 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.511 ' N ' ' NE2' ' A' ' 2' ' ' GLN . 31.2 ttp . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 1' ' ' MET . 5.7 mp0 -87.65 -177.95 5.98 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.514 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 14.7 pt -147.7 143.43 19.64 Favored 'Isoleucine or valine' 0 C--O 1.232 0.151 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.217 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.491 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -94.99 115.29 27.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.071 179.818 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 5' ' ' VAL . 31.8 m -102.96 128.93 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.256 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.587 -179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -88.69 107.12 18.77 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.461 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -85.06 -174.14 50.16 Favored Glycine 0 CA--C 1.525 0.718 0 N-CA-C 111.656 -0.578 . . . . 0.0 111.656 -179.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 47.3 mt -62.73 -41.56 99.23 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.818 0.342 . . . . 0.0 110.601 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.4 m -66.75 -22.12 66.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.816 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 95.26 1.44 62.63 Favored Glycine 0 CA--C 1.523 0.568 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 -179.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -81.61 138.74 35.31 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.761 0.315 . . . . 0.0 110.423 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 14.1 p -88.35 129.2 35.46 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.47 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.414 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.3 m -115.79 111.26 20.25 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.005 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 37.0 p -72.13 109.84 6.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.803 -179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 62.7 mt -98.09 143.33 28.74 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.494 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -84.2 117.54 23.57 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 31.8 m -142.05 163.08 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.426 ' O ' ' N ' ' A' ' 21' ' ' ASP . 47.0 mt-10 -145.02 150.58 46.18 Favored Pre-proline 0 CA--C 1.533 0.292 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.838 179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_exo -39.3 -48.2 3.15 Favored 'Trans proline' 0 N--CA 1.491 1.365 0 C-N-CA 122.132 1.888 . . . . 0.0 112.313 179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.6 p -67.51 -30.91 70.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.908 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 18' ' ' GLU . 27.6 t70 -56.64 120.12 7.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.988 0.423 . . . . 0.0 110.812 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.8 p -80.47 164.74 22.79 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.413 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 26.8 mm -62.82 -42.12 95.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.444 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 75.3 tt0 -44.79 -44.73 9.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.383 179.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 53.5 t-20 -66.19 -46.08 78.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.586 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 47.3 t -52.89 -45.5 51.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.412 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -65.04 -34.65 78.92 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.851 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.41 -44.02 88.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.807 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 47.6 mmtt -62.37 -41.26 98.48 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.69 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.451 HG21 ' NE2' ' A' ' 41' ' ' GLN . 78.3 mt -64.29 -44.56 97.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.188 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -57.56 -17.39 13.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.657 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 32.7 t0 -85.77 -10.53 55.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.479 179.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -115.69 -16.81 11.22 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.514 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 52.5 p -112.47 -33.07 6.28 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.185 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.78 77.73 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 179.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 81.7 mt -79.23 131.8 64.87 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 121.058 -0.257 . . . . 0.0 110.634 -179.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -41.47 156.91 0.06 OUTLIER 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 121.848 1.699 . . . . 0.0 111.486 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -61.27 -33.96 88.87 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.985 1.79 . . . . 0.0 111.239 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 13.0 p-10 -80.07 -2.11 42.92 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.758 179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 2.8 mm100 -107.54 11.97 28.19 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 120.78 0.324 . . . . 0.0 110.377 179.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' NE2' HG21 ' A' ' 30' ' ' ILE . 47.7 tp60 -111.49 147.59 34.99 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.394 -179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 42.3 ttm180 -151.61 135.11 16.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.39 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 87.2 mt -125.25 130.44 52.06 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.782 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 63.0 mt -137.35 123.04 26.24 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.593 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -117.77 130.2 56.15 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.022 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 54.89 24.51 5.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.619 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 87.23 -15.31 54.56 Favored Glycine 0 CA--C 1.524 0.623 0 N-CA-C 111.133 -0.787 . . . . 0.0 111.133 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 63.8 mttp -79.79 133.25 36.29 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -86.98 130.27 34.53 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.838 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.6 mt -86.16 149.97 24.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.407 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 98.7 mt-10 -139.81 140.62 36.65 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.509 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 72.3 m-20 -47.39 153.71 0.49 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.345 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 84.1 14.61 71.59 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 31.0 mmt180 -129.47 148.31 51.37 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 120.878 0.37 . . . . 0.0 110.238 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 37.7 p -109.39 173.41 6.33 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.338 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 48.6 mt -66.77 -36.2 81.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.051 0.453 . . . . 0.0 110.296 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.0 p -62.7 -16.88 59.34 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.092 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -84.9 -41.27 16.12 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.005 0.431 . . . . 0.0 110.213 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -84.07 -4.18 58.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.371 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 65.53 25.81 11.76 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.257 -179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 57.9 mt -74.16 129.86 36.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.427 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 59.0 mt-30 -112.57 -161.2 0.74 Allowed 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.512 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 73.7 tttt -74.61 154.89 38.35 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.985 0.421 . . . . 0.0 110.759 -179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 55.93 31.68 18.31 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.309 179.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.44 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 0.6 OUTLIER -75.1 130.38 39.17 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.387 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.421 ' C ' HD22 ' A' ' 67' ' ' LEU . 17.0 m -84.75 112.96 20.97 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 121.139 0.495 . . . . 0.0 111.144 -179.172 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.7 mm? -93.38 -164.94 1.24 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.603 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 82.8 m-70 -153.92 115.68 4.23 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.87 0.367 . . . . 0.0 110.537 179.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 89.5 mt -105.29 112.65 39.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.851 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 16.2 m -118.54 139.98 43.85 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.389 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.11 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 27.8 t90 -141.86 116.24 9.55 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.972 0.415 . . . . 0.0 110.712 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.6 ttm-85 -157.65 116.94 3.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.29 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 23.0 mt -76.01 114.26 14.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.711 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 72.2 ttt180 -92.02 147.69 22.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.549 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 82.65 -151.69 29.55 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 110.916 -0.873 . . . . 0.0 110.916 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.771 0 CA-C-O 118.009 -1.44 . . . . 0.0 110.987 179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.506 ' SD ' ' O ' ' A' ' 1' ' ' MET . 8.8 tmm? . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.22 -0.659 . . . . 0.0 109.22 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.414 ' HG2' ' H ' ' A' ' 2' ' ' GLN . 3.2 pt20 -90.23 -173.75 3.94 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.78 -179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 20.7 pt -147.97 143.9 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.479 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.483 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.0 119.9 37.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.677 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 13' ' ' THR . 0.2 OUTLIER -87.82 133.95 29.16 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.181 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 52.7 mttp -126.44 93.56 3.83 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.242 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -77.45 -168.55 30.87 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 59.7 mt -45.27 -67.86 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.709 0.29 . . . . 0.0 110.834 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 51.7 p -138.76 4.96 2.36 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.802 -179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -65.24 156.72 47.77 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.769 -0.933 . . . . 0.0 110.769 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 48.4 mtmt -66.52 143.79 56.86 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.353 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 9.0 m -63.83 138.86 58.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.277 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.488 ' O ' HG22 ' A' ' 5' ' ' VAL . 3.1 m -135.27 148.98 49.71 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.945 -179.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 28.0 p -103.67 146.59 28.36 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.391 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 17.4 mt -130.56 137.58 49.75 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.968 0.414 . . . . 0.0 110.918 -179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -81.45 119.79 24.18 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.641 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.9 m -141.62 167.38 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.27 0 CA-C-O 120.889 0.376 . . . . 0.0 110.488 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.408 ' H ' ' HB2' ' A' ' 21' ' ' ASP . 31.0 mt-10 -137.74 149.41 64.54 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.816 179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -42.05 -32.78 1.99 Allowed 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 121.609 1.539 . . . . 0.0 112.21 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 18.5 p -83.05 -27.59 30.18 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.632 -179.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.408 ' HB2' ' H ' ' A' ' 18' ' ' GLU . 33.9 m-20 -54.28 123.06 11.72 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.672 -0.411 . . . . 0.0 110.729 -179.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 59.6 p -81.16 163.78 22.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.518 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.6 mm -63.71 -42.24 95.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.698 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 61.0 tt0 -47.9 -42.77 27.79 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.957 -0.386 . . . . 0.0 109.957 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.414 ' OD1' ' C ' ' A' ' 25' ' ' ASN . 27.3 t-20 -65.27 -46.18 81.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.995 179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 52.4 t -54.12 -44.98 65.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.049 -179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' O ' ' NE2' ' A' ' 41' ' ' GLN . 97.7 mttt -64.53 -35.43 80.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.376 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -66.28 -41.22 90.13 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 179.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.7 mmtt -63.95 -42.73 97.22 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.659 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.485 ' C ' ' H ' ' A' ' 32' ' ' ASP . 84.5 mt -62.95 -41.9 94.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.531 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -52.92 -7.14 0.07 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.836 -179.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.485 ' H ' ' C ' ' A' ' 30' ' ' ILE . 22.7 m-20 -91.36 -37.51 13.19 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.153 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.8 mttm -91.38 -17.98 24.98 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.326 -179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 63.8 p -104.44 -34.83 8.12 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-O 120.888 0.375 . . . . 0.0 110.064 179.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.11 72.3 0.6 Allowed Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.525 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -154.98 155.4 30.2 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.12 163.13 12.41 Favored 'Trans proline' 0 N--CA 1.496 1.659 0 C-N-CA 122.316 2.01 . . . . 0.0 111.405 179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.413 ' C ' ' H ' ' A' ' 40' ' ' GLN . 38.6 Cg_endo -65.51 -27.92 53.8 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.659 2.239 . . . . 0.0 112.214 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 25.8 p30 -70.74 5.45 1.92 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.756 -0.378 . . . . 0.0 110.485 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.413 ' H ' ' C ' ' A' ' 38' ' ' PRO . 78.9 mt-30 -122.39 4.07 9.69 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.547 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.419 ' NE2' ' O ' ' A' ' 27' ' ' LYS . 90.0 mt-30 -104.97 134.02 48.78 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 120.986 0.422 . . . . 0.0 111.0 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.534 ' HE ' HE21 ' A' ' 49' ' ' GLN . 73.3 ttt180 -152.33 130.77 12.14 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.015 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 74.9 mt -122.02 132.99 54.8 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-O 121.007 0.432 . . . . 0.0 111.134 -179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 67.2 mt -137.49 123.86 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 115.7 -0.682 . . . . 0.0 109.695 179.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -117.07 129.82 56.25 Favored 'General case' 0 N--CA 1.465 0.3 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 179.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 52.2 33.71 13.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.567 -179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.2 -25.4 4.89 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.19 -0.764 . . . . 0.0 111.19 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -71.75 133.68 45.73 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.83 0.348 . . . . 0.0 110.755 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.534 HE21 ' HE ' ' A' ' 42' ' ' ARG . 47.3 tt0 -87.03 133.58 33.58 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.349 -179.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 17.5 mt -88.56 150.88 22.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.546 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -142.76 142.69 31.97 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.524 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.7 t0 -60.42 107.74 0.71 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.701 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.66 0.18 0.83 Allowed Glycine 0 CA--C 1.525 0.7 0 N-CA-C 110.794 -0.922 . . . . 0.0 110.794 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.423 ' HE ' ' HB3' ' A' ' 58' ' ' ASP . 77.0 mtp180 -131.62 147.57 52.53 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 120.748 0.308 . . . . 0.0 110.494 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 40.1 p -94.98 177.74 5.79 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.004 0.431 . . . . 0.0 110.911 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 39.8 mt -66.89 -38.67 86.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.172 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 96.1 p -64.04 -18.96 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.861 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 49.4 m-20 -82.62 -41.86 18.95 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-O 120.895 0.378 . . . . 0.0 110.015 179.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 65.4 m-85 -80.25 -1.21 39.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.343 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 7.3 m-80 66.53 24.94 10.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.472 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 82.7 mt -77.16 133.44 30.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.534 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -118.55 -152.15 0.5 Allowed 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.88 157.31 26.98 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.907 -179.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 47.73 26.86 0.95 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.839 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.447 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 2.0 m -69.07 128.77 37.87 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' C ' HD22 ' A' ' 67' ' ' LEU . 7.1 m -82.66 112.38 19.48 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-O 121.067 0.46 . . . . 0.0 111.725 -178.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.71 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.9 mm? -92.4 -177.56 4.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.58 -0.736 . . . . 0.0 109.274 178.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.523 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 31.1 m170 -145.93 120.68 9.87 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.826 0.345 . . . . 0.0 110.778 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 88.8 mt -97.71 111.36 27.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.962 -0.563 . . . . 0.0 109.546 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 5.3 t -90.27 98.5 8.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.784 0.326 . . . . 0.0 110.499 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 33.5 t90 -98.62 116.71 31.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.346 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.7 ttt-85 -160.83 108.43 1.54 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.621 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 22.0 mt -78.24 143.65 36.91 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.111 179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 76.7 mtp85 -70.98 148.74 47.35 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.731 -179.689 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -60.8 -33.37 82.74 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.784 0 CA-C-O 118.01 -1.439 . . . . 0.0 110.923 179.925 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.4 ptt? . . . . . 0 N--CA 1.489 1.525 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 92.5 mt-30 -93.33 172.01 8.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.526 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 25.7 pt -148.84 145.35 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.182 0 CA-C-O 121.003 0.43 . . . . 0.0 110.713 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.459 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.6 m-85 -98.85 128.91 45.18 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.409 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' HG23 ' A' ' 5' ' ' VAL . 22.0 m -111.28 133.4 56.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.287 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -86.2 136.85 33.03 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.98 179.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -151.46 -175.48 23.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 120.99 -0.624 . . . . 0.0 111.598 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.521 HD12 ' H ' ' A' ' 8' ' ' LEU . 5.2 mp -81.28 -10.19 59.63 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.727 0.298 . . . . 0.0 110.973 -179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.3 p -59.76 -13.84 11.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.911 -179.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 83.11 -0.53 89.71 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.5 pttt -144.93 155.71 43.57 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 67.9 p -82.7 162.18 21.87 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.786 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -128.09 111.4 13.45 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.132 -0.485 . . . . 0.0 109.852 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 21.3 p -70.51 120.66 16.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.544 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.6 mt -115.01 148.34 38.96 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.665 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -93.67 120.56 34.1 Favored 'General case' 0 N--CA 1.462 0.133 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.911 178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.6 m -143.78 163.38 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.227 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.53 -179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 54.4 mm-40 -143.09 153.09 59.75 Favored Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.031 -179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -42.35 -39.43 6.42 Favored 'Trans proline' 0 N--CA 1.491 1.373 0 C-N-CA 121.995 1.797 . . . . 0.0 112.065 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 81.8 p -74.25 -30.87 62.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.869 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -59.43 113.77 2.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.542 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 40.5 p -76.09 164.96 25.61 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.125 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.3 mm -60.9 -40.97 87.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.484 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 82.4 tt0 -47.71 -45.71 28.85 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.391 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -63.27 -43.88 96.7 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.317 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 28.8 t -55.95 -47.97 79.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.44 -179.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mtmt -60.06 -35.65 75.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.039 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -64.88 -43.56 92.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.336 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 61.9 mmtt -63.53 -42.61 98.43 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.144 0.497 . . . . 0.0 109.739 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.444 ' C ' ' H ' ' A' ' 32' ' ' ASP . 89.7 mt -63.29 -46.81 94.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.421 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.5 tt0 -51.12 -11.55 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.648 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 30' ' ' ILE . 40.1 t0 -88.34 -39.21 14.53 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.824 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -87.43 -15.37 37.93 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.138 -179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.425 ' OG1' HD11 ' A' ' 36' ' ' LEU . 70.2 p -107.25 -34.0 7.25 Favored 'General case' 0 N--CA 1.467 0.375 0 CA-C-O 120.923 0.392 . . . . 0.0 110.341 179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 57.6 67.32 2.27 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.628 -0.589 . . . . 0.0 111.628 179.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.0 154.38 28.79 Favored Pre-proline 0 CA--C 1.538 0.506 0 N-CA-C 110.256 -0.275 . . . . 0.0 110.256 179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_exo -42.77 155.99 0.11 Allowed 'Trans proline' 0 N--CA 1.491 1.363 0 C-N-CA 121.867 1.711 . . . . 0.0 111.837 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -71.84 -27.85 17.36 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.366 2.044 . . . . 0.0 111.416 179.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -79.3 1.12 26.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -106.42 10.59 31.43 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.023 179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.504 HE21 HD11 ' A' ' 36' ' ' LEU . 91.7 mt-30 -111.34 145.52 38.71 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.743 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 73.6 ttt180 -140.5 126.45 19.49 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.174 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 53.9 mt -123.84 126.87 47.2 Favored 'General case' 0 N--CA 1.467 0.424 0 CA-C-O 121.049 0.452 . . . . 0.0 110.881 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 88.8 mt -138.91 124.83 23.27 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.759 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -117.11 133.83 55.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.057 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 50.72 17.19 0.37 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.824 0.345 . . . . 0.0 110.627 179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 100.84 -26.89 22.96 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 111.009 -0.836 . . . . 0.0 111.009 179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -71.42 136.11 47.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.696 0.284 . . . . 0.0 110.543 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -87.06 133.22 33.62 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 120.985 0.421 . . . . 0.0 110.847 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.2 mt -88.01 146.92 25.25 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.303 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -148.66 161.51 41.57 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.124 179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.3 p-10 -67.23 153.29 44.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.83 0.347 . . . . 0.0 110.277 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 92.02 4.65 66.76 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 72.7 mtt-85 -132.41 144.46 50.52 Favored 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 19.5 p -103.07 175.66 5.4 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.324 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 62.9 mt -62.63 -34.07 76.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.106 0.479 . . . . 0.0 110.19 179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 83.2 p -64.68 -15.71 61.75 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.353 -179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -85.11 -42.02 15.17 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.912 0.387 . . . . 0.0 110.228 179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -84.17 0.55 48.22 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.506 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 62.74 27.39 16.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.882 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 59.4 mt -74.41 136.9 24.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.585 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -122.66 -158.59 0.79 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.423 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 74.9 tttt -76.9 152.02 35.53 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.859 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 57.67 26.33 12.84 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.768 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.407 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.4 m -70.21 128.01 34.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.429 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.426 ' C ' HD22 ' A' ' 67' ' ' LEU . 12.3 m -84.66 113.56 21.37 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.089 0.471 . . . . 0.0 111.375 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.703 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.5 mm? -93.63 -170.92 2.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.259 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.541 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 33.2 m170 -147.69 116.59 6.79 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.715 179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 3.7 pt -119.78 106.85 19.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 3.7 m -105.49 131.95 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.342 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 34.4 t90 -108.88 109.9 21.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.264 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 66.4 ttt180 -156.26 131.16 9.11 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.585 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 29.6 mt -89.01 161.34 16.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.663 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -75.04 158.64 32.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.313 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 164.16 -85.15 0.1 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.745 0 CA-C-O 117.943 -1.476 . . . . 0.0 110.754 179.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 9.9 ptt? . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 75.1 mt-30 -95.33 171.86 8.45 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.395 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 17.0 pt -148.12 149.63 15.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.966 0.412 . . . . 0.0 111.095 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.439 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.8 m-85 -102.67 129.05 49.16 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.845 -0.616 . . . . 0.0 109.501 178.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 31.2 m -107.9 135.99 44.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.846 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -84.2 115.0 22.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.586 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -91.64 178.16 40.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 73.3 mt -64.3 -41.93 96.63 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.901 0.381 . . . . 0.0 110.803 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.9 p -77.57 -7.07 55.77 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.595 -179.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 90.39 -6.36 82.38 Favored Glycine 0 CA--C 1.524 0.601 0 N-CA-C 110.6 -1.0 . . . . 0.0 110.6 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -67.32 126.62 29.83 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 21.2 p -85.71 135.5 33.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.668 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 1.2 m -118.66 114.28 22.5 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.922 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 36.9 p -73.08 119.18 16.97 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.522 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 5.4 mt -113.39 140.76 47.78 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.439 -179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 82.0 tt0 -87.58 121.28 29.81 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.918 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.3 m -142.22 161.94 19.52 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.904 0.383 . . . . 0.0 110.885 -179.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -127.86 153.46 78.1 Favored Pre-proline 0 N--CA 1.467 0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.602 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -56.08 -36.93 96.93 Favored 'Trans proline' 0 N--CA 1.496 1.639 0 C-N-CA 122.062 1.841 . . . . 0.0 112.005 -179.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 70.6 m -79.46 -2.84 43.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.877 0.37 . . . . 0.0 110.416 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.546 ' CG ' HD22 ' A' ' 25' ' ' ASN . 22.0 t0 -78.36 125.69 29.71 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.81 -179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 71.4 p -83.97 161.9 20.61 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.096 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 25.0 mm -59.22 -41.03 82.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.38 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 81.2 tt0 -45.51 -46.75 14.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.877 0.37 . . . . 0.0 110.216 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.546 HD22 ' CG ' ' A' ' 21' ' ' ASP . 53.1 t30 -65.65 -43.26 89.98 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.468 179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 51.0 t -56.67 -44.85 82.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.286 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -62.49 -35.75 80.35 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -65.83 -43.27 89.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.95 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 58.5 mmtt -63.96 -43.82 94.64 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' C ' ' H ' ' A' ' 32' ' ' ASP . 80.8 mt -61.36 -42.57 94.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.268 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 56.3 tt0 -49.45 -11.18 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.481 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.478 ' H ' ' C ' ' A' ' 30' ' ' ILE . 23.1 m-20 -82.71 -34.89 27.16 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.208 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.5 mmtt -99.03 -4.69 31.89 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.316 -179.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 67.5 p -122.07 -44.74 2.28 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 121.018 0.437 . . . . 0.0 110.104 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 49.92 71.62 0.59 Allowed Glycine 0 CA--C 1.527 0.81 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.176 179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.554 HD12 ' O ' ' A' ' 36' ' ' LEU . 0.3 OUTLIER -155.61 153.8 26.96 Favored Pre-proline 0 CA--C 1.535 0.386 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 178.593 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -39.43 156.25 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 C-N-CA 122.111 1.874 . . . . 0.0 111.876 -179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.07 -20.99 24.54 Favored 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.334 2.023 . . . . 0.0 111.46 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -82.29 2.28 32.79 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.285 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -112.82 3.12 16.24 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.763 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 61.6 tt0 -113.03 144.86 41.87 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.842 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -141.11 138.71 33.7 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.06 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 97.5 mt -129.9 121.77 27.31 Favored 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.969 0.414 . . . . 0.0 110.422 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.503 ' O ' ' ND1' ' A' ' 68' ' ' HIS . 96.7 mt -137.16 125.22 32.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.951 179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -117.05 117.33 29.35 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.124 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 61.09 31.84 19.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.852 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 85.25 -12.44 58.38 Favored Glycine 0 CA--C 1.527 0.827 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 179.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' NZ ' HH22 ' A' ' 54' ' ' ARG . 82.6 tttt -86.86 130.82 34.31 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 120.737 0.303 . . . . 0.0 110.401 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 57.0 tt0 -85.5 132.39 34.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.053 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.8 mt -87.04 147.18 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.768 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 81.0 mm-40 -135.65 149.83 49.43 Favored 'General case' 0 N--CA 1.466 0.37 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.35 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 10.3 p-10 -68.43 112.08 5.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.929 0.395 . . . . 0.0 110.504 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 142.9 1.03 1.19 Allowed Glycine 0 CA--C 1.524 0.654 0 N-CA-C 110.376 -1.089 . . . . 0.0 110.376 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.587 HH22 ' NZ ' ' A' ' 48' ' ' LYS . 76.5 mtp180 -134.23 150.41 51.04 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 16.2 p -103.23 -177.46 3.38 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.893 0.378 . . . . 0.0 110.576 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 53.0 mt -64.88 -39.24 93.24 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.333 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 25.8 p -63.45 -20.08 65.27 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.994 -179.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.403 ' HB3' ' HE ' ' A' ' 54' ' ' ARG . 94.5 m-20 -83.09 -42.19 17.71 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.882 0.372 . . . . 0.0 110.447 179.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -82.0 -0.62 45.03 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.336 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.2 t30 66.05 24.34 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.386 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 79.8 mt -75.94 129.52 36.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.377 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 65.1 mt-30 -116.35 -154.17 0.55 Allowed 'General case' 0 N--CA 1.466 0.361 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.959 -179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -80.3 151.02 29.76 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.913 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 59.07 23.77 12.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.83 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.471 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.9 m -68.15 124.56 23.77 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.406 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.0 m -82.42 113.46 20.2 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 121.059 0.456 . . . . 0.0 111.288 -179.295 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.708 HD22 ' N ' ' A' ' 67' ' ' LEU . 2.6 mm? -92.59 -173.57 3.4 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.524 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 28.4 m80 -145.84 118.06 8.38 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.9 0.381 . . . . 0.0 110.806 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 86.2 mt -101.65 111.29 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.137 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.3 t -105.75 124.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.682 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 36.8 t90 -146.51 110.57 5.01 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.958 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 67.3 ttp85 -153.3 150.01 28.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.444 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.626 HD22 ' N ' ' A' ' 73' ' ' LEU . 3.2 mm? -80.19 136.33 36.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.509 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 71.0 ttt180 -76.19 134.88 39.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.406 179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 56.88 -143.56 39.9 Favored Glycine 0 CA--C 1.527 0.791 0 N-CA-C 111.036 -0.826 . . . . 0.0 111.036 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.744 0 CA-C-O 118.069 -1.406 . . . . 0.0 110.88 179.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 47.7 ttp . . . . . 0 N--CA 1.49 1.567 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -87.76 175.65 7.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.223 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 28.7 pt -146.9 141.97 20.39 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 179.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 4' ' ' PHE . 1.9 m-30 -98.37 118.91 36.09 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.102 0.477 . . . . 0.0 110.807 -179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 13' ' ' THR . 0.0 OUTLIER -84.49 123.8 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 CA-C-N 115.729 -0.668 . . . . 0.0 109.835 179.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 63.7 tttp -97.1 115.28 27.22 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.784 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.71 174.48 46.37 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 32.6 mt -62.94 -44.31 96.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.789 0.328 . . . . 0.0 110.389 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 64.8 p -148.87 -21.73 0.31 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.454 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -56.07 -172.8 0.14 Allowed Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.141 -0.783 . . . . 0.0 111.141 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -90.61 146.16 24.28 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.949 0.404 . . . . 0.0 110.826 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 13' ' ' THR . 31.9 m -63.53 164.31 9.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.278 179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 12' ' ' THR . 5.0 m -155.13 144.45 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-O 120.992 0.425 . . . . 0.0 111.0 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 71.1 p -95.18 150.63 20.0 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.033 -0.531 . . . . 0.0 109.831 179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.3 mt -137.06 131.33 32.61 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.791 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -74.66 116.71 15.67 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.1 m -141.91 157.0 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.084 0.468 . . . . 0.0 111.061 -179.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -129.97 151.85 78.97 Favored Pre-proline 0 CA--C 1.531 0.229 0 CA-C-N 115.663 -0.698 . . . . 0.0 109.153 179.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -56.53 -16.42 18.6 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 121.9 1.734 . . . . 0.0 112.086 -179.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 93.5 p -93.99 -10.2 34.41 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.871 179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -75.46 124.54 27.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.804 0.335 . . . . 0.0 110.641 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.1 p -78.33 163.52 25.64 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.055 179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 20.8 mm -61.06 -30.48 47.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.512 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 74.4 tt0 -56.96 -45.87 82.55 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.988 -0.375 . . . . 0.0 109.988 179.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -65.15 -42.54 93.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.007 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 49.1 t -57.78 -45.94 87.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.307 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -62.36 -35.4 79.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.303 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ALA . . . . . . . . . . . . . . . -63.49 -38.84 92.66 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.256 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 36.9 mmtm -67.64 -43.74 79.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.096 179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.431 ' C ' ' H ' ' A' ' 32' ' ' ASP . 82.9 mt -60.91 -42.32 92.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.791 -179.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -55.56 -6.23 0.18 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.32 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.431 ' H ' ' C ' ' A' ' 30' ' ' ILE . 45.0 m-20 -103.88 -6.91 20.88 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.661 0.267 . . . . 0.0 111.026 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -109.66 -33.45 6.77 Favored 'General case' 0 N--CA 1.467 0.391 0 CA-C-N 116.508 -0.315 . . . . 0.0 111.164 -179.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.3 p -111.89 -33.2 6.37 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 120.879 0.371 . . . . 0.0 110.708 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 72.11 22.21 78.91 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 111.488 -0.645 . . . . 0.0 111.488 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.828 HD21 ' NE1' ' A' ' 71' ' ' TRP . 16.0 mt -84.99 147.6 48.49 Favored Pre-proline 0 CA--C 1.535 0.375 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -72.97 161.09 44.46 Favored 'Trans proline' 0 N--CA 1.494 1.556 0 C-N-CA 122.073 1.849 . . . . 0.0 110.984 178.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -57.94 -33.1 96.7 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.439 2.093 . . . . 0.0 112.361 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -70.07 -2.81 13.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.125 -179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.516 ' OE1' HD11 ' A' ' 73' ' ' LEU . 70.3 mt-30 -130.33 6.19 4.87 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.012 0.434 . . . . 0.0 109.844 179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -103.99 82.67 2.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.187 -179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 63.8 ttm-85 -101.08 126.64 47.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 46.7 mt -112.78 132.03 55.43 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-O 120.948 0.404 . . . . 0.0 110.319 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . . . . . . . . . 71.4 mt -138.26 123.9 24.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.013 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -115.18 124.45 51.49 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . 55.69 21.87 4.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.653 -179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 94.61 -11.31 70.16 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -84.15 124.46 31.17 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.79 0.328 . . . . 0.0 110.507 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.6 tt0 -78.88 132.05 36.65 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.724 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.1 mt -89.13 150.59 22.64 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.96 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -147.81 154.97 41.16 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.874 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -63.24 145.5 55.4 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.92 -0.312 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.21 11.14 43.24 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 110.899 -0.88 . . . . 0.0 110.899 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -138.77 143.13 38.83 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-O 120.755 0.312 . . . . 0.0 110.377 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 31.9 p -94.55 174.6 7.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.427 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 80.6 mt -66.12 -35.04 79.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 32.5 t -65.15 -18.25 65.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.695 -0.684 . . . . 0.0 111.221 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -78.17 -39.49 40.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.162 0.506 . . . . 0.0 109.915 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 86.3 m-85 -84.26 2.55 39.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.803 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 63.82 25.98 14.22 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.761 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 67.2 mt -76.13 132.65 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.61 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -118.42 -153.3 0.53 Allowed 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.557 -179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -78.94 159.51 27.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.964 0.412 . . . . 0.0 110.882 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 48.89 19.45 0.27 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.011 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' SER . . . . . 0.417 ' O ' ' CD2' ' A' ' 67' ' ' LEU . 1.7 m -66.08 130.86 44.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.664 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.447 ' C ' HD22 ' A' ' 67' ' ' LEU . 6.2 m -84.43 113.59 21.3 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.085 0.469 . . . . 0.0 111.07 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.709 HD22 ' N ' ' A' ' 67' ' ' LEU . 3.2 mm? -95.81 111.01 23.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.496 -0.774 . . . . 0.0 109.765 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -75.56 119.12 19.18 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.539 -0.464 . . . . 0.0 110.559 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.8 pt -105.04 113.85 43.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 179.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.8 t -91.21 111.19 23.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.16 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.828 ' NE1' HD21 ' A' ' 36' ' ' LEU . 47.5 t90 -117.6 111.67 19.5 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.674 -179.507 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 43.0 ttm180 -171.61 114.46 0.37 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.285 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.557 ' N ' HD12 ' A' ' 73' ' ' LEU . 10.4 mp -79.64 142.8 35.25 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.031 0.443 . . . . 0.0 110.418 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -62.3 -45.81 91.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.298 -179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 59.72 -141.59 47.5 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 110.509 -1.036 . . . . 0.0 110.509 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.22 -0.746 0 CA-C-O 117.975 -1.458 . . . . 0.0 111.111 179.79 . . . . . . . . 0 0 . 1 stop_ save_